U.S. Markets closed

Agilent Technologies and Three More Healthcare Stocks Under Our Scanner

Stock Research Monitor: CFMS, XRAY, and BIOC

LONDON, UK / ACCESSWIRE / May 17, 2018/ If you want a free Stock Review on A sign up now at www.wallstequities.com/registration. On Wednesday, May 16, 2018, the NASDAQ Composite ended the trading session at 7,398.30, up 0.63%; the Dow Jones Industrial Average edged 0.25% higher, to finish at 24,768.93; and the S&P 500 closed at 2,722.46, slightly advancing 0.41%. Gains were broad based as eight out of nine sectors ended the day in positive. This Thursday, WallStEquities.com has initiated reports coverage on the following Healthcare equities: ConforMIS Inc. (NASDAQ: CFMS), DENTSPLY SIRONA Inc. (NASDAQ: XRAY), Agilent Technologies Inc. (NYSE: A), and Biocept Inc. (NASDAQ: BIOC). All you have to do is sign up today for this free limited time offer by clicking the link below.



Billerica, Massachusetts headquartered ConforMIS Inc.'s stock finished Wednesday's session 2.19% lower at $1.34 with a total trading volume of 380,145 shares. The stock is trading below its 50-day moving average by 6.71%. Additionally, shares of ConforMIS, which develops, manufactures, and sells joint replacement implants, have a Relative Strength Index (RSI) of 43.43.Get the full research report on CFMS for free by clicking below at:



On Wednesday, shares in York, Pennsylvania headquartered DENTSPLY SIRONA Inc. recorded a trading volume of 2.48 million shares, which is above its three months average volume of 2.46 million shares. The stock ended the session 0.10% lower at $47.89. The stock is trading below its 50-day moving average by 6.16%. Moreover, shares of DENTSPLY SIRONA, which designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide, have an RSI of 43.53.

On May 08th, 2018, research firm H.C. Wainwright reiterated its ‘Neutral' rating on the Company's stock with a decrease of the target price from $63 a share to $52 a share. Get access to our top-rated research, including the free report on XRAY at:


Agilent Technologies

Santa Clara, California headquartered Agilent Technologies Inc.'s shares closed the day 0.90% lower at $61.94. The stock recorded a trading volume of 5.63 million shares, which is above its three months average volume of 2.72 million shares. The Company's shares have gained 8.99% over the last twelve months. The stock is trading below its 50-day moving average by 8.28%. Additionally, shares of Agilent Technologies, which provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide, have an RSI of 31.46. Click here to subscribe for a free membership which welcomes you with our report on A at:



Shares in San Diego, California headquartered Biocept Inc. finished 13.64% lower at $0.19. The stock recorded a trading volume of 2.34 million shares, which is above its three months average volume of 2.21 million shares. The stock is trading below its 50-day moving average by 28.82%. Furthermore, shares of Biocept, which develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample, have an RSI of 30.44. Join our big investor community at Wall St. Equities today and get your free report on BIOC at:


Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.


WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit



For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com

Phone number: 21 32 044 483

Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities